Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

How the Vac4covid study will collect data

Written by | 7 Apr 2021

Interview and article by Christine Clark. Gavin Dobson, Clinical Trials Pharmacist at MEMO Research explains the practical details of the Vac4covid study. The Vac4covid study will recruit at… read more.

Studying people’s experience of covid-19 vaccination – Vac4covid

Written by | 6 Apr 2021

Interview and article by Christine Clark. The Vac4covid study has been designed to provide important data about the safety and effectiveness of covid-19 vaccines. IMI interviewed Mr Gavin… read more.

AZD 1222 US Phase III primary analysis confirms safety and efficacy for prevention of COVID-19 – AstraZeneca

Written by | 27 Mar 2021

Positive high-level results from the primary analysis of the Phase III trial of AZD 1222 in the US have confirmed vaccine efficacy consistent with the pre-specified interim analysis… read more.

Real world evidence from Peru and Colombia confirms ivermectin safe and effective

Written by | 27 Mar 2021

Interview and article by Christine Clark. The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and… read more.

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

Interview and article by Christine Clark. The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin,… read more.

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent… read more.

Real world evidence from Israeli Ministry of Health analysis confirms high effectiveness of the Pfizer-BioNTech COVID 19 vaccine

Written by | 24 Mar 2021

The Israel Ministry of Health (MoH), Pfizer Inc. and BioNTech SE announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the… read more.

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Interview and article by Christine Clark Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a… read more.

UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective

Written by | 22 Mar 2021

The Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.

Interim SAGE/WHO recommendation supporting the use of the Johnson & Johnson COVID-19 Vaccine

Written by | 18 Mar 2021

Johnson & Johnson welcomes the interim recommendation by the Strategic Advisory Group of Experts (SAGE) on Immunization for the World Health Organization (WHO) supporting the use of Johnson… read more.

EU grants conditional approval for single-dose COVID-19 vaccine JNJ 78436735 – Johnson & Johnson

Written by | 18 Mar 2021

Johnson & Johnson announced that the European Commission (EC) has granted a Conditional Marketing Authorization (CMA) for its single-dose COVID-19 vaccine JNJ 78436735, developed by the Janssen Pharmaceutical… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.